Profile
Raising capital is a key challenge for executives at early-stage therapeutics companies. Lumerate is launching the BioBackers investor intelligence platform to simplify the search for ideal-fit investors by helping you pinpoint firms whose specific investment interests – stage, therapeutic focus, geography, and more – align with your company's profile. Stop the ineffective random outreach and instead discover the right partners actively seeking ventures like yours, enabling meaningful connections for your next venture funding round.
Event details
Name: Ontario at BIO 2025
Date: June 16 - 19, 2025
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
23 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for… -
Since 2001, BioScript Solutions has supported patients with chronic illnesses and rare diseases by providing… -
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of… -
Dalriada is a leading North American discovery company pioneering its novel Turn-Key™ model in small molecule… -
HDAX Therapeutics, a biotechnology company pioneering a novel approach to target HDAC6 to address… -
ImmunoBiochem is an innovative biopharmaceutical company developing novel bioconjugate therapeutics, such … -
Invest Ontario is a provincial agency dedicated to securing private sector strategic business and capital… -
Raising capital is a key challenge for executives at early-stage therapeutics companies. Lumerate is launching… -
mDETECT offers highly sensitive and cost-effective blood tests that can measure tumour behaviour irrespective of… -
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small… -
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both GLP… -
Paradox Immunotherapeutics is a biotech addressing the global burden of protein misfolding diseases—devastating… -
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead… -
QReserve provides powerful enterprise-grade scheduling and resource management software to world-class… -
Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number… -
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and… -
Sussex Research Laboratories Inc. (Ottawa, Canada) is recognized as a leader in the design and synthesis of… -
SYNG Pharma is developing a new first-in-class diagnostic test and non-hormonal therapy for endometriosis. The… -
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide… -
VeriLuce Therapeutics is an early-stage drug company developing novel small molecules targeting in dual… -
Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the… -
YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress…